Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of MK-0873 Following Patch Application in Healthy Participants and Psoriasis Participants (MK-0873-020) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability and pharmacokinetics of MK-0873 after patch application in healthy participants and participants with plaque psori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• MK-0873 (MK-0873)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Plaque Psoriasis | Phase 1 | Status: COMPLETED | Results posted: 2014-12-12